Intraoperative breast cancer margin evaluation using fluorescence imaging with intravenous injection of indocyanine green (BREASTIFLU-1): study protocol for a randomized diagnostic accuracy trial of quantitative dose-timing assessment
Evaluate the effectiveness of fluorescence imaging for assessing breast cancer margins during surgery.
Randomized diagnostic accuracy trial design
Intravenous injection of indocyanine green
Quantitative assessment of dose-timing
Comparison of margin evaluation techniques
Expected improvement in diagnostic accuracy for margin evaluation
Potential reduction in reoperation rates for breast cancer
Enhanced visualization of tumor margins during surgery
Abstract
This trial was registered on February 15, 2023 at Clinical Trials Information System EU2023-504024-26-00 and on September 10, 2023 at ClinicalTrials.gov NCT06227338.